Abstract
The sudden emergence of infectious diseases pose threats to societies worldwide and it is notably difficult to detect. In the past few years, several early warning signals (EWS) were introduced, to alert to impending critical transitions and extend the set of indicators for risk assessment. While they were originally thought to be generic, recent works demonstrated their sensitivity to some dynamical characteristics such as system noise and rates of approach to critical parameter values. Moreover, testing on empirical data is so far limited. Hence, validating their performance remains a challenge. In this study, we analyse the performance of common EWS such as increasing variance and autocorrelation in detecting the emergence of COVID-19 outbreaks in various countries, based on prevalence data. We show that EWS are successful in detecting disease emergence provided that some basic assumptions are satisfied: a slow forcing through the transitions and not fat-tailed noise. We also show cases where EWS fail, thus providing a verification analysis of their potential and limitations. Overall, this suggests that EWS can be useful for active monitoring of epidemic dynamics, but that their performance is sensitive to surveillance procedures. Our results thus represent a further step towards the application of EWS indicators for informing public health policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DP's and SM's work is supported by the FNR PRIDE DTU CriTiCS, ref 10907093. FK's work is supported by the Luxembourg National Research Fund PRIDE17/12244779/PARK-QC. JG is partly supported by the 111 Project on Computational Intelligence and Intelligent Control, ref B18024.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Luxembourg
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The analysis was performed in Matlab and Python. They require the Statistics Toolbox and the scipy library, respectively. Code and curated data are accessible on: https://github.com/daniele-proverbio/EWS_epidemic.
